| P50 | author | Luis Garcia-Marcos | Q50942292 |
| P2093 | author name string | M Fernández Benítez | |
| | M Navarro Merino | |
| | A Escribano Montaner | |
| | J A Castillo Laita | |
| | C González Díaz | |
| | J R Villa Asensi | |
| | J Sanz Ortega | |
| | C Pardos Martínez | |
| | Groupo de trabajo para el Consenso sobre Tratamiento del Asma Infantil | |
| | J De Benito Fernández | |
| | J Garde Garde | |
| | J Pellegrini Belinchon | |
| | J Sánchez Jiménez | |
| | M Ibero Iborra | |
| | S García de la Rubia | |
| P2860 | cites work | Written individualised management plans for asthma in children and adults | Q24247458 |
| | Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths | Q28244453 |
| | Characterization of within-subject responses to fluticasone and montelukast in childhood asthma | Q28306277 |
| | Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering beta (2 )agonists bronchodilators in asthma | Q28362346 |
| | Effects of educational interventions for self management of asthma in children and adolescents: systematic review and meta-analysis | Q30478140 |
| | Childhood wheezing syndromes and healthcare data | Q30808070 |
| | Effectiveness and tolerability of zafirlukast for the treatment of asthma in children | Q31423025 |
| | The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma. | Q33211376 |
| | The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old. | Q33211769 |
| | Syndrome: le mot de jour | Q33356889 |
| | Use of budesonide in severe asthmatics aged 1-3 years | Q33623852 |
| | Efficacy of cromoglycate in persistently wheezing infants | Q33625114 |
| | Immunotherapy in asthma: an updated systematic review | Q33760677 |
| | Acute asthma in the pediatric emergency department | Q33813807 |
| | ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. | Q34409752 |
| | What have we learned from the Tucson Children's Respiratory Study? | Q34958363 |
| | Scheduled follow-up after a pediatric emergency department visit for asthma: a randomized trial | Q35075561 |
| | Noninjection routes for immunotherapy | Q35087289 |
| | Stabilization of asthma prevalence among adolescents and increase among schoolchildren (ISAAC phases I and III) in Spain. | Q53283092 |
| | The effect of inhaled budesonide on symptoms, lung function, and cold air and methacholine responsiveness in 2- to 5-year-old asthmatic children. | Q54033764 |
| | Ipratropium bromide added to asthma treatment in the pediatric emergency department | Q57529027 |
| | Intermittent Inhaled Corticosteroids in Infants with Episodic Wheezing | Q57638228 |
| | Persistent Wheezing in Very Young Preschool Children Reflects Lower Respiratory Inflammation | Q57638299 |
| | The Effect of Inhaled Fluticasone Propionate in the Treatment of Young Asthmatic Children | Q57638329 |
| | Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma | Q57638373 |
| | A comparison of inhaled budesonide and beclomethasone dipropionate in childhood asthma | Q68187244 |
| | Errors in inhalation technique and efficiency in inhaler use in asthmatic children | Q69504753 |
| | Anti-inflammatory therapy reduces wheezing after bronchiolitis | Q71055578 |
| | Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study | Q71423244 |
| | Asthma and wheezing in the first six years of life. The Group Health Medical Associates | Q72356528 |
| | A comparison between nebulized terbutaline, nebulized corticosteroid and systemic corticosteroid for acute wheezing in children up to 18 months of age | Q72851212 |
| | Sodium cromoglycate as a replacement for inhaled corticosteroids in mild-to-moderate childhood asthma | Q73039726 |
| | A clinical index to define risk of asthma in young children with recurrent wheezing | Q73071756 |
| | Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma. Budesonide Inhalation Suspension Study Group | Q73076882 |
| | Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial | Q73900956 |
| | Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma | Q74098152 |
| | Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group | Q74471633 |
| | Bronchoalveolar lavage findings suggest two different forms of childhood asthma | Q74810200 |
| | Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide | Q77222405 |
| | Oral versus intravenous corticosteroids in children hospitalized with asthma | Q77313296 |
| | Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma | Q77357671 |
| | Asthma therapy with aerosols: are nebulizers obsolete? A continuing controversy | Q77960387 |
| | Standards for practical allergen-specific immunotherapy | Q80162252 |
| | [Geographic variation in the prevalence of asthma symptoms in Spanish children and adolescents. International Study of Asthma and Allergies in Childhood (ISAAC) Phase 3, Spain] | Q82060867 |
| | Long-term inhaled corticosteroids in preschool children at high risk for asthma | Q83316436 |
| | Family history and the risk of early-onset persistent, early-onset transient, and late-onset asthma | Q35103831 |
| | Tucson Children's Respiratory Study: 1980 to present | Q35110736 |
| | Nebulised cromoglycate, theophylline, and placebo in preschool asthmatic children | Q35115182 |
| | Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing | Q35262745 |
| | A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide | Q35267839 |
| | Outpatient management of childhood asthma by paediatrician or asthma nurse: randomised controlled study with one year follow up | Q35535532 |
| | Asthma education. | Q35543643 |
| | Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood | Q35563236 |
| | Fluticasone propionate in asthma: a long term dose comparison study | Q35571425 |
| | Nebulised sodium cromoglycate in recurrently wheezy preschool children | Q35602108 |
| | Inhaled budesonide for chronic wheezing under 18 months of age | Q35627902 |
| | Written action plans for asthma: an evidence-based review of the key components | Q35647705 |
| | Impact of nurse-led outpatient management of children with asthma on healthcare resource utilisation and costs | Q35673690 |
| | beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. | Q35854031 |
| | Optimizing inhaled corticosteroid therapy in children with chronic asthma | Q35942577 |
| | Large volume spacer devices and the influence of high dose beclomethasone dipropionate on hypothalamo-pituitary-adrenal axis function | Q36276414 |
| | Nitric oxide as a clinical guide for asthma management | Q36388264 |
| | Consensus statement on the management of paediatric asthma. | Q36495905 |
| | Sublingual immunotherapy in the treatment of children | Q36515380 |
| | Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence | Q37282612 |
| | Two subphenotypes of childhood asthma that differ in maternal and paternal influences on asthma risk | Q39042362 |
| | Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma | Q39342252 |
| | Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma | Q39374605 |
| | Intravenous versus oral corticosteroids in the management of acute asthma in children | Q39439742 |
| | Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study). | Q39475402 |
| | Short-term outcomes after acute treatment of pediatric asthma | Q39569554 |
| | Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation | Q39587121 |
| | Factors associated with preventive asthma care in inner-city children | Q39698111 |
| | Therapeutic aerosols 2--Drugs available by the inhaled route | Q40093004 |
| | Therapeutic aerosols 1--physical and practical considerations | Q40169201 |
| | Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study. | Q40468074 |
| | Pharmacokinetic optimisation of asthma treatment | Q40624935 |
| | Egg allergy in infancy predicts respiratory allergic disease by 4 years of age. | Q40748710 |
| | Early detection of specific IgE antibody against house dust mite in children at risk of allergic disease | Q40939109 |
| | Airway responsiveness in wheezy infants: evidence for functional beta adrenergic receptors | Q41127081 |
| | Age-dependency of alpha- and beta-adrenoceptors on thrombocytes and lymphocytes of asthmatic and nonasthmatic children | Q41528941 |
| | Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers | Q41602389 |
| | Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group | Q41706736 |
| | How to choose delivery devices for asthma | Q41856361 |
| | Slow release theophylline in preschool asthmatics | Q41864560 |
| | Controlled trial of budesonide given by the nebuhaler in preschool children with asthma | Q41874250 |
| | Comparison of the efficacy of inhaled fluticasone propionate, 880 microg/day, with flunisolide, 1500 microg/day, in moderate-to-severe persistent asthma | Q42050311 |
| | Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study | Q42686117 |
| | Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma | Q43517116 |
| | Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study. | Q43601132 |
| | Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma | Q44161807 |
| | A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis | Q44198475 |
| | Children with mild asthma: do they benefit from inhaled corticosteroids? | Q44263405 |
| | Response to montelukast among subgroups of children aged 2 to 14 years with asthma | Q44409436 |
| | A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children | Q44582256 |
| | Facemasks versus mouthpieces for aerosol treatment of asthmatic children | Q44631980 |
| | Effects of inhaled fluticasone propionate in children less than 2 years old with recurrent wheezing | Q44733659 |
| | Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma | Q44841358 |
| | Fatalities from immunotherapy (IT) and skin testing (ST) | Q44852137 |
| | Is bronchodilator response in 2-yr-old children associated with asthma risk factors? | Q45014734 |
| | Efficacy and safety of inhaled corticosteroids in combination with a long-acting beta2-agonist in asthmatic children under age 5. | Q45053714 |
| | Salbutamol via metered-dose inhaler with spacer versus nebulization for acute treatment of pediatric asthma in the emergency department | Q45083457 |
| | Effect of nebulized ipratropium on the hospitalization rates of children with asthma | Q45113976 |
| | Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants | Q45143046 |
| | Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma | Q45150106 |
| | Fluticasone improves pulmonary function in children under 2 years old with risk factors for asthma | Q45183030 |
| | Inhaled corticosteroids during and after respiratory syncytial virus-bronchiolitis may decrease subsequent asthma | Q45740714 |
| | Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years | Q45747463 |
| | Nebulised sodium cromoglycate in the treatment of wheezy bronchitis. A multicentre double-blind placebo controlled study. | Q45934200 |
| | A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants | Q46206581 |
| | Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study | Q46630095 |
| | Comparison of roflumilast, an oral anti-inflammatory, with beclomethasone dipropionate in the treatment of persistent asthma | Q46858436 |
| | The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol | Q46902379 |
| | Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. | Q47387899 |
| | Characterization of wheezing phenotypes in the first 10 years of life | Q47906199 |
| | Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma | Q48423257 |
| | A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma | Q48562860 |
| | Inhaled budesonide for treatment of recurrent wheezing in early childhood | Q48920350 |
| | Nebulised sodium cromoglycate in the treatment of wheezy bronchitis in infants and young children | Q49156983 |
| | Natural course of sensitization to food and inhalant allergens during the first 6 years of life. | Q50648208 |
| | Validation of a hand-held exhaled nitric oxide analyzer for use in children. | Q51155194 |
| | Differential cytology of bronchoalveolar lavage fluid in asthmatic children. | Q51682665 |
| | Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma. | Q53229520 |
| P433 | issue | 3 | |
| P304 | page(s) | 253-273 | |
| P577 | publication date | 2007-09-01 | |
| P1433 | published in | Anales de Pediatria Continuada | Q15760182 |
| P1476 | title | [Consensus on the treatment of asthma in pediatrics] | |
| P478 | volume | 67 | |